Genmab reported DKK5M in Interest Expense on Debt for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Amgen AMGN:US USD 415M 47M
Biomarin Pharmaceutical BMRN:US USD 3.63M 1.05M
Fresenius Medical Care FME:GR EUR 100.07M 7.53M
Galapagos GLPG:NA EUR 1.04M 681K
Genmab GEN:DC DKK 5M 1000K
Immunogen IMGN:US USD 971K 104K
Insmed INSM:US USD 16.44M 13.09M
Lonza Group LONN:SW CHF 32M 4M
Novartis NOVN:VX USD 219M 4M
Regeneron Pharmaceuticals REGN:US USD 17.4M 2.1M
Roche Holding ROG:VX 348M 92M